Clinical Trials Browser

Phase 1 × Capecitabine × Tumor-Agnostic × Clear all

NCT01061515 2025-09-17

Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

Phase 1 Active not recruiting

Carcinoma

NCT02794571 2024-12-05

Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors

Phase 1 Completed

Neoplasm Metastasis

NCT02483247 2023-11-14

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

Phase 1 Completed

Neoplasms

NCT01226732 2022-03-08

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Phase 1 Completed

23 enrolled 12 charts

Neoplasm Metastasis

NCT00207129 2017-01-30

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

Phase 1 Completed

Neoplasms

NCT00811993 2016-11-02

A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

Phase 1 Terminated

Neoplasms

NCT00798252 2015-07-07

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis

NCT00707278 2014-10-31

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

Phase 1 Completed

Neoplasms

NCT00838370 2014-03-04

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Phase 1 Completed

Neoplasms

NCT00660426 2013-04-23

Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors

Phase 1 Completed

Neoplasms

NCT00613145 2013-02-04

Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00849550 2012-12-24

COBRA

Phase 1 Completed

Neoplasms

NCT00454649 2012-04-04

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Phase 1 Completed

102 enrolled 48 charts

Neoplasms

NCT00329329 2012-03-23

Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies

Phase 1 Terminated

Neoplasms

NCT00390676 2010-12-28

A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

Phase 1 Completed

Neoplasms

NCT00249977 2010-01-07

Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan

Phase 1 Completed

Neoplasms